| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | CONNECTURE INC | 1,740,000 | 18,374,000 | 0.15% | ||
| 52 | Pieris Pharmaceuticals | 7,259,620 | 19,964,000 | 0.17% | ||
| 53 | ABBVIE INC | 300,000 | 20,157,000 | 0.17% | Call | |
| 54 | JAZZ PHARMACEUTICALS PLC | 115,000 | 20,248,000 | 0.17% | ||
| 55 | MIRATI THERAPEUTICS INC COM | 680,500 | 21,415,000 | 0.18% | ||
| 56 | XENCOR INC COM | 1,044,615 | 22,950,000 | 0.19% | ||
| 57 | ZIMMER BIOMET HLDGS INC | 212,300 | 23,190,000 | 0.19% | ||
| 58 | CYNAPSUS THERAPEUTICS INC | 1,140,325 | 23,274,000 | 0.19% | ||
| 59 | MERCK & CO INC | 415,000 | 23,626,000 | 0.20% | ||
| 60 | Ascendis Pharma | 1,448,991 | 25,618,000 | 0.21% | ||
| 61 | BIOMARIN PHARMACEUTICAL INC | 188,000 | 25,715,000 | 0.21% | ||
| 62 | SYNERGY PHARMACEUTICALS DEL | 3,121,148 | 25,906,000 | 0.22% | ||
| 63 | GALAPAGOS NV | 512,900 | 26,414,000 | 0.22% | ||
| 64 | ASSEMBLY BIOSCIENCES INC | 1,397,100 | 26,908,000 | 0.22% | ||
| 65 | UNITEDHEALTH GROUP INC | 238,000 | 29,036,000 | 0.24% | ||
| 66 | DYAX CORP COM CVR | 1,117,000 | 29,601,000 | 0.25% | ||
| 67 | ProQR Therapeutics NV | 1,831,400 | 30,529,000 | 0.26% | ||
| 68 | ADURO BIOTECH INC | 1,065,522 | 32,317,000 | 0.27% | ||
| 69 | INCYTE CORP SR NT CONV 4.750% 10/01/15 B/EDTD 03/30/10 0221 UBS FINANCIAL SERVICES INC. A/C MR06471 | 2,742,000 | 32,436,000 | 0.27% | PRN | |
| 70 | HORIZON PHARMA PLC | 951,000 | 33,038,000 | 0.28% | ||
| 71 | BRISTOL MYERS SQUIBB CO | 500,000 | 33,270,000 | 0.28% | Call | |
| 72 | XENOPORT INC | 5,768,400 | 35,360,000 | 0.30% | ||
| 73 | FORWARD PHARMA A/S | 960,600 | 36,551,000 | 0.31% | ||
| 74 | VALEANT PHARMACEUTICALS INTL | 165,000 | 36,655,000 | 0.31% | ||
| 75 | PORTOLA PHARMACEUTICALS INC | 850,700 | 38,749,000 | 0.32% | ||
| 76 | LOXO ONCOLOGY INC COM | 2,175,857 | 39,231,000 | 0.33% | ||
| 77 | GW PHARMACEUTICALS PLC | 325,000 | 39,923,000 | 0.33% | ||
| 78 | SPDR S&P 500 ETF TR | 200,000 | 41,170,000 | 0.34% | Put | |
| 79 | INSMED INC | 1,708,500 | 41,722,000 | 0.35% | ||
| 80 | CERUS CORP | 8,307,727 | 43,117,000 | 0.36% | ||
| 81 | CHIMERIX INC | 1,021,600 | 47,198,000 | 0.39% | ||
| 82 | MEDTRONIC PLC | 646,300 | 47,891,000 | 0.40% | ||
| 83 | INFINITY PHARMACEUTICALS INC | 4,416,300 | 48,358,000 | 0.40% | ||
| 84 | Otonomy Inc | 2,256,398 | 51,875,000 | 0.43% | ||
| 85 | EXACT SCIENCES CORP | 1,778,000 | 52,878,000 | 0.44% | ||
| 86 | FLUIDIGM CORP DEL COM | 2,449,900 | 59,288,000 | 0.50% | ||
| 87 | JOHNSON & JOHNSON | 617,000 | 60,133,000 | 0.50% | ||
| 88 | NUVASIVE INC | 1,487,000 | 70,454,000 | 0.59% | ||
| 89 | ARRAY BIOPHARMA INC | 10,060,500 | 72,536,000 | 0.61% | ||
| 90 | AFFIMED N V COM | 5,814,630 | 78,323,000 | 0.65% | ||
| 91 | SIENTRA INC | 3,185,306 | 80,365,000 | 0.67% | ||
| 92 | ADAPTIMMUNE THERAPEUTICS PLC | 4,411,186 | 80,857,000 | 0.68% | ||
| 93 | AFFYMETRIX INCOC-CAP STK CASH MGREFF 4/1/16 1 OLDUSD 14.00 PER SHARE | 7,511,000 | 82,020,000 | 0.69% | ||
| 94 | GLAUKOS CORP | 2,897,937 | 83,982,000 | 0.70% | ||
| 95 | OPHTHOTECH CORP | 1,674,600 | 87,180,000 | 0.73% | ||
| 96 | WRIGHT MEDICAL GROUP NV | 3,337,000 | 87,630,000 | 0.73% | ||
| 97 | CLOVIS ONCOLOGY INC | 1,005,200 | 88,337,000 | 0.74% | ||
| 98 | MALLINCKRODT PUB LTD CO | 795,000 | 93,587,000 | 0.78% | ||
| 99 | INSYS THERAPEUTICS INC NEW COM NEW | 2,623,000 | 94,218,000 | 0.79% | ||
| 100 | COMMUNITY HEALTH SYS INC NEW | 1,530,000 | 96,344,000 | 0.81% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001654, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
